Cas:2566-44-1 2-Cyclopropylethanol manufacturer & supplier

We serve Chemical Name:2-Cyclopropylethanol CAS:2566-44-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Cyclopropylethanol

Chemical Name:2-Cyclopropylethanol
CAS.NO:2566-44-1
Synonyms:2-Cyclopropylethanol;cyclopropylethanol;2-Cyclopropylethan-1-Ol;2-cyclopropyl-ethanol;2-Cyclopropylethyl alcohol;2-Cyclopropyl-aethanol;MFCD00040762;Cyclopropaneethanol
Molecular Formula:C5H10O
Molecular Weight:86.132
HS Code:2906199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:127.3±8.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.471
PSA:20.23000
Exact Mass:86.073166
LogP:0.71

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1987
Packing Group:III


Contact us for information like 2-Cyclopropylethanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cyclopropaneethanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,cyclopropylethanol Use and application,2-cyclopropyl-ethanol technical grade,usp/ep/jp grade.


Related News: Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world. 2-Cyclopropylethanol manufacturer Slower growth in pesticide intermediates weighed on industrial business. In the first three quarters, the company’s operating income was 2.977 billion yuan, a year-on-year increase of 2.57%. 2-Cyclopropylethanol supplier As one of the world’s largest API producers and exporters, China’s chemical API production and operating income show steady growth. 2-Cyclopropylethanol vendor Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world. 2-Cyclopropylethanol factory A number of factors influenced the decision by the U.S. Centers for Disease Control and Prevention, including the COVID-19 pandemic, too few facilities to quarantine dogs safely and three recent incidents where rabies-infected dogs were brought into the country, CNN reported.